These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3318904)

  • 21. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amelioration by muramyl dipeptide of the effect of induced hyperferremia upon Klebsiella infection in mice.
    Brewer RJ; Galland RB; Polk HC
    Infect Immun; 1982 Oct; 38(1):175-8. PubMed ID: 6754611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukotriene B4 receptor (BLT-1) modulates neutrophil influx into the peritoneum but not the lung and liver during surgically induced bacterial peritonitis in mice.
    Scott MJ; Cheadle WG; Hoth JJ; Peyton JC; Subbarao K; Shao WH; Haribabu B
    Clin Diagn Lab Immunol; 2004 Sep; 11(5):936-41. PubMed ID: 15358656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The protection from hepatotoxicity of some compounds by the synthetic immunomodulator muramyl dipeptide (MDP) in rat hepatocytes and in vivo.
    Farghali H; Machková Z; Kameníková L; Jankü I; Masek K
    Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):449-54. PubMed ID: 6492941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of long-term administration of levamisole and muramyl-dipeptide on phagocytic activity of polymorphonuclear leukocytes in relation to the age of rats].
    Nicák A; Mirossay L; Mojzis J; Kohút A
    Bratisl Lek Listy; 1994 Jan; 95(1):21-3. PubMed ID: 7922620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunostimulating agents against influenza virus infection in senescent rats.
    Ganguly R; Park J
    Allerg Immunol (Leipz); 1988; 34(4):239-47. PubMed ID: 3228058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muramyl dipeptide protects decomplemented mice from surgically-induced infection.
    Cobb JP; Brown CM; Brown GL; Polk HC
    Int J Immunopharmacol; 1986; 8(7):799-803. PubMed ID: 3781709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic influences on the adjuvanticity of muramyl dipeptide in vivo.
    Staruch MJ; Wood DD
    J Immunol; 1982 Jan; 128(1):155-60. PubMed ID: 6976368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-dependent effects of aminobutyryl muramyl dipeptide on alveolar macrophage function in infant and adult Macaca monkeys.
    Jacobs RF; Wilson CB; Smith AL; Haas JE
    Am Rev Respir Dis; 1983 Nov; 128(5):862-7. PubMed ID: 6638675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of muramyl dipeptide analogs in combination with trehalose dimycolate against aerogenic influenza virus and Mycobacterium tuberculosis infections in mice.
    Masihi KN; Brehmer W; Lange W; Ribi E; Schwartzman S
    J Biol Response Mod; 1984 Dec; 3(6):663-71. PubMed ID: 6439830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.
    Parant M; Parant F; Chedid L
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3395-9. PubMed ID: 356054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog.
    Osada Y; Otani T; Sato M; Une T; Matsumoto K; Ogawa H
    Infect Immun; 1982 Dec; 38(3):848-54. PubMed ID: 6295949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analogues of muramyl dipeptide (MDP) and tuftsin limit infection and inflammation in murine model of sepsis.
    Wardowska A; Dzierzbicka K; Szaryńska M; Dabrowska-Szponar M; Wiśniewska K; Myśliwski A; Trzonkowski P
    Vaccine; 2009 Jan; 27(3):369-74. PubMed ID: 19027810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DUOX2 promotes the elimination of the Klebsiella pneumoniae strain K5 from T24 cells through the reactive oxygen species pathway.
    Lu H; Wu Q; Yang H
    Int J Mol Med; 2015 Aug; 36(2):551-8. PubMed ID: 26046128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of muramyl dipeptide on immunogenicity of Corynebacterium pseudotuberculosis whole-cell vaccines in mice and lambs.
    Brogden KA; Chedid L; Cutlip RC; Lehmkuhl HD; Sacks J
    Am J Vet Res; 1990 Feb; 51(2):200-2. PubMed ID: 2301830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Function of polymorphonuclear neutrophilic leucocytes. Comparison of leucocytes from blood and exudate in healthy volunteers.
    Wandall JH
    Acta Pathol Microbiol Immunol Scand C; 1982 Feb; 90(1):7-13. PubMed ID: 7044042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
    Souvannavong V; Adam A
    Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of mouse resistance to bacterial infection with muramyl dipeptide glycoside.
    Kalyuzhin OV; Kalina NG; Bashtanenko AF; Shkalev MV; Kuzovlev FN; Kalyuzhin VV
    Bull Exp Biol Med; 2003 May; 135(5):452-5. PubMed ID: 12910284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Containment as a mechanism of nonspecific enhancement of defenses against bacterial infection.
    Polk HC; Lamont PM; Galland RB
    Infect Immun; 1990 Jun; 58(6):1807-11. PubMed ID: 2187809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.